Tuesday May 8 | AmericanBankingNews.com
Integramed America Price Target Increased to $15.50 by Analysts at Dougherty & Co
The firm currently has a "buy" rating on the stock. Shares of Integramed America traded down 0.08% during mid-day trading on Tuesday, hitting $12.86. Integramed America has a one year low of $6.70 and a one year high of $13.50. The company has a market cap of $154.0 million and a P/E ratio of 30.86. IntegraMed America, Inc.
IntegraMed America's CEO Discusses Q1 2012 Results - Earnings Call Transcript
Good morning everyone and thank you for participating in IntegraMed America Inc.
IntegraMedA Q1 EPS Rose 38% to $0.11 on Revenue Growth of 10% to $71M
IntegraMed America, Inc. , the leader in developing, marketing and managing specialty healthcare facilities in the fertility and vein care markets, today announced results for the first quarter ended March 31, 2012.